Effect of pneumococcal conjugate vaccine on pneumococcal meningitis - Wikidata - awgldk - TriplyDB

Effect of pneumococcal conjugate vaccine on pneumococcal meningitis

Effect of pneumococcal conjugate vaccine on pneumococcal meningitis

http://www.wikidata.org/entity/Q34015633

about

Pre-admission antibiotics for suspected cases of meningococcal disease Pre-admission antibiotics for suspected cases of meningococcal disease Immunostimulants for preventing respiratory tract infection in children Pathophysiology and treatment of bacterial meningitis A Review of Pneumococcal Vaccines: Current Polysaccharide Vaccine Recommendations and Future Protein Antigens Meningococcal B vaccine and the vision of a meningitis free world Pneumococcal disease and use of pneumococcal vaccines in Taiwan Dissecting the indirect effects caused by vaccines into the basic elements Clinical implications of pneumococcal serotypes: invasive disease potential, clinical presentations, and antibiotic resistance Pathogens penetrating the central nervous system: infection pathways and the cellular and molecular mechanisms of invasion From the microbiome to the central nervous system, an update on the epidemiology and pathogenesis of bacterial meningitis in childhood Higher pneumococcal disease vaccination rates needed to protect more at-risk US adults.Contribution of vaccines to our understanding of pneumococcal disease.Epidemiology, diagnosis, and antimicrobial treatment of acute bacterial meningitis.Molecular analysis improves pathogen identification and epidemiologic study of pediatric parapneumonic empyema Streptococcus pneumoniae serotype 19A in Latin America and the Caribbean: a systematic review and meta-analysis, 1990-2010.Self-reported pediatricians' management of the well-appearing young child with fever without a source: first survey in an European country in the anti-pneumococcal vaccine era.African meningitis belt pneumococcal disease epidemiology indicates a need for an effective serotype 1 containing vaccine, including for older children and adults Realtime PCR is more sensitive than multiplex PCR for diagnosis and serotyping in children with culture negative pneumococcal invasive disease Dynamic models of pneumococcal carriage and the impact of the Heptavalent Pneumococcal Conjugate Vaccine on invasive pneumococcal disease.Epidemiological profile of meningococcal disease in the United States Population structure and capsular switching of invasive Neisseria meningitidis isolates in the pre-meningococcal conjugate vaccine era--United States, 2000-2005 Pneumococcal Vaccination Strategies. An Update and Perspective.Factors associated with ceftriaxone nonsusceptibility of Streptococcus pneumoniae: analysis of South African national surveillance data, 2003 to 2010.Changes in capsule and drug resistance of Pneumococci after introduction of PCV7, Japan, 2010-2013.The causative organisms of bacterial meningitis in Korean children in 1996-2005.Streptococcus pneumoniae clonal complex 199: genetic diversity and tissue-specific virulence Options for inactivation, adjuvant, and route of topical administration of a killed, unencapsulated pneumococcal whole-cell vaccine.Pneumonia and poverty: a prospective population-based study among children in Brazil Incorporation of real-time PCR into routine public health surveillance of culture negative bacterial meningitis in São Paulo, Brazil.Re-emergence of the type 1 pilus among Streptococcus pneumoniae isolates in Massachusetts, USA.A novel protein, RafX, is important for common cell wall polysaccharide biosynthesis in Streptococcus pneumoniae: implications for bacterial virulence Pertussis in Florida, 2000-2006: trends in a historically low-incidence state Enhanced determination of Streptococcus pneumoniae serotypes associated with invasive disease in Laos by using a real-time polymerase chain reaction serotyping assay with cerebrospinal fluid.Effects of pneumococcal conjugate vaccine 2 years after its introduction, the Netherlands.Streptococcus pneumoniae translocates into the myocardium and forms unique microlesions that disrupt cardiac function.Bacterial causes of empyema in children, Australia, 2007-2009.GMP-grade pneumococcal whole-cell vaccine injected subcutaneously protects mice from nasopharyngeal colonization and fatal aspiration-sepsis.Development of Streptococcus pneumoniae Vaccines Using Live Vectors Invasive pneumococcal disease in healthy adults: increase of empyema associated with the clonal-type Sweden(1)-ST306.

P2860

Q24200590-086A6F2B-491F-4FEB-BC89-5CA52AE49954 Q24242705-C74755A6-7142-4CCD-8725-34F3AF311EDC Q24243914-2EA8C375-9A3A-4075-9DC2-66FD17B759D6 Q24628983-C1760926-F7A2-40F9-9F64-67B27742FFC6 Q26753152-F53B445E-490A-4488-89AF-4E939FDDA6A6 Q26770696-D13DA374-6E90-428F-BA51-0F464DA00A93 Q26798168-94E1D13A-90A9-49B8-840F-FDC2C9943832 Q26799527-B6FF9B07-53B8-47BD-AFE2-67952E7CB49E Q26851961-D4EA8259-AFA6-4194-ABB6-E9D2F7A1DC92 Q27027234-6575F8A5-91EB-40BB-BBA5-39843F8A7B1D Q29248091-0C1078C1-C913-463B-BFA4-7AABC8DEB8B9 Q30382878-8F98F6F5-9D77-45C2-980B-9EC93AC12164 Q30406750-17EBAA54-3191-4FB9-BA8B-D5F0F764BD2A Q30431534-2EDD6E61-B3A1-4C4A-9D10-D7B37E097733 Q30498477-728AEEBC-4685-4460-B220-5B85D7049CB5 Q31063000-DAEC509A-320D-40A7-A00D-02AA2BD1D44A Q33494765-A0C7FB27-2437-42E0-A723-87714AF94E99 Q33530554-43350616-F83B-4A71-A639-F7A0F06806C7 Q33533300-415831C2-7A3E-4361-8348-6894D7148F0B Q33551026-3162A5AF-435C-44B9-BDD8-8C457B5E5106 Q33648635-B68EAC3A-F7B7-47E8-AFD6-772CDBCCEDF1 Q33729202-219C0CB4-14C3-4BEA-923D-C800E9DA5206 Q33772409-B240A6FF-094D-4AD5-AB0B-FAD152F20AD2 Q33798133-FECFBC38-84D3-4F1A-AC76-B168E1B1AC82 Q33816288-0627D872-8165-453C-AA53-E953B96175D4 Q33879697-6F9736D1-D671-49D0-8D00-2C00A39B32B2 Q33886611-58D7EA3B-4C2E-41FA-B755-DD43857EBA8A Q33909187-AC462E13-18F2-47F2-927C-A9EDF3E76D2F Q33940163-81F23F31-349C-44AC-9F46-328A4166E693 Q33952107-AC127B18-1EB6-4049-A7A5-DC296DB2C791 Q33965380-83AF9F6B-1884-49CA-B6FE-5F2A4DDBF162 Q34056914-20B87978-51F1-4AE8-9D5C-4F5DFB944130 Q34077277-FB95C259-2F9D-4404-97C1-B02C96EC36FE Q34087265-DB0F8B5D-0E21-481A-99A2-9C0C33DB903B Q34194058-5B35A563-1012-49B5-8BD3-D9ADC538254D Q34215330-07D8D103-2572-4D14-9194-7D22AD28DF2B Q34224472-31122FED-7428-4F15-AA0B-EE342ADBA1C7 Q34310321-290E8DD5-B5C7-422C-8B2B-59BB6AF85AD4 Q34316015-C8C23788-34CB-4C2A-8E0C-87CDA456E4FD Q34388781-7BDD044C-C2F5-40C1-A5A4-66F3AEDF4941

P2860

Effect of pneumococcal conjugate vaccine on pneumococcal meningitis

http://www.wikidata.org/entity/Q34015633

description

2009 nî lūn-bûn

@nan

2009 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Effect of pneumococcal conjugate vaccine on pneumococcal meningitis

@ast

Effect of pneumococcal conjugate vaccine on pneumococcal meningitis

@en

Effect of pneumococcal conjugate vaccine on pneumococcal meningitis

@nl

type

label

Effect of pneumococcal conjugate vaccine on pneumococcal meningitis

@ast

Effect of pneumococcal conjugate vaccine on pneumococcal meningitis

@en

Effect of pneumococcal conjugate vaccine on pneumococcal meningitis

@nl

prefLabel

Effect of pneumococcal conjugate vaccine on pneumococcal meningitis

@ast

Effect of pneumococcal conjugate vaccine on pneumococcal meningitis

@en

Effect of pneumococcal conjugate vaccine on pneumococcal meningitis

@nl

P1433

Q34015633-66EBA856-FE91-446A-B55F-46F93BBF47D4

P1476

Q34015633-1F092415-754F-4575-B6F9-393478F8A299

P2093

Q34015633-1438E686-8EB3-4319-880C-9C30AB5A05B7

Q34015633-1CE97EB9-1259-45F2-B557-49D15EC348CB

Q34015633-2073C44A-E8EA-4708-ADA9-6268B60B1DE8

Q34015633-4515C98A-1A3E-4505-BB7F-102D9994A90D

Q34015633-5CF610CB-0DCA-4D85-8811-2098DA4CADBE

Q34015633-79C053A8-9D03-4716-9160-7D66288C0465

Q34015633-801DAFA1-A333-4910-9950-EACDD282A5D3

Q34015633-86EC2B87-86DF-4A22-AA5B-FD8D6FCE6C89

Q34015633-A3D5DFD0-A33C-4C1A-BCD0-40D3D68BB532

Q34015633-B7958BC5-B363-4954-923A-DD0B2A24D575

P2860

Q34015633-1255CAF5-20F8-4865-9BA6-4A8B9029039E

Q34015633-1D71C544-B2AF-4000-8196-772D66DC23CC

Q34015633-2F643E3B-820F-41DB-A072-6760305ED98A

Q34015633-402C18C0-F83B-436C-8644-B30CE19C55F2

Q34015633-4C853708-347D-4FA9-8A86-5AB502871697

Q34015633-624228F0-1283-480D-A1FD-C12383385E56

Q34015633-88996467-227F-4EF1-8CDB-9A4101269208

Q34015633-8A7ECA74-5ABF-4F64-979C-6BFEC5DDCAE2

Q34015633-8C100B8A-FD66-46C8-AC10-45DE802C4F45

Q34015633-8CEADC51-BAB6-4C4E-AB46-38A545B75733

P304

Q34015633-4A353358-FACC-4403-BAE9-8DCFF48A6964

P31

Q34015633-C142919C-364F-466B-AA13-AD9FD9A9E166

P356

Q34015633-E8A1943B-3C12-4E27-AC53-B98AB78ACDED

P407

Q34015633-B8C00313-1A62-4A4F-8BDD-D221316B8150

P433

Q34015633-9E9A2C4C-D995-4660-84C6-B1BEDBC989BA

P478

Q34015633-CAE36648-0E03-400C-8133-81892CFB5A0B

P50

Q34015633-848F1AFA-5F02-4791-BD67-226E22714A05

Q34015633-EC8C5C9E-8E1B-47F0-B413-1B74BBE179BB

P577

Q34015633-F577D268-36AC-4749-A11E-521FD1CBE5CA

P698

Q34015633-CC6D854B-8ACF-4071-89A5-A5067E7EDEC9

P921

Q34015633-4C69DA7B-4E0A-4572-BD93-6496F7DA424C

P932

Q34015633-4705D2EC-C060-4772-A483-915929E2D20C

P356

P1433

The New England Journal of Medicine

P1476

Effect of pneumococcal conjugate vaccine on pneumococcal meningitis

@en

P2093

Allen S Craig

http://www.w3.org/2001/XMLSchema#string

Ann Thomas

http://www.w3.org/2001/XMLSchema#string

Arthur Reingold

http://www.w3.org/2001/XMLSchema#string

Bernard W Beall

http://www.w3.org/2001/XMLSchema#string

Catherine A Lexau

http://www.w3.org/2001/XMLSchema#string

Cynthia G Whitney

http://www.w3.org/2001/XMLSchema#string

Heather E Hsu

http://www.w3.org/2001/XMLSchema#string

James H Jorgensen

http://www.w3.org/2001/XMLSchema#string

Lee H Harrison

http://www.w3.org/2001/XMLSchema#string

Matthew R Moore

http://www.w3.org/2001/XMLSchema#string

P2860

Decline in Invasive Pneumococcal Disease after the Introduction of Protein–Polysaccharide Conjugate Vaccine

Effectiveness of seven-valent pneumococcal conjugate vaccine against invasive pneumococcal disease: a matched case-control study

Invasive pneumococcal disease among infants before and after introduction of pneumococcal conjugate vaccine

Policy Statement: Recommendations for the Prevention of Pneumococcal Infections, Including the Use of Pneumococcal Conjugate Vaccine (Prevnar), Pneumococcal Polysaccharide Vaccine, and Antibiotic Prophylaxis

Practice guidelines for the management of bacterial meningitis.

Bacterial meningitis in the United States in 1995. Active Surveillance Team.

Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998-2004.

Discovery of a new capsular serotype (6C) within serogroup 6 of Streptococcus pneumoniae.

Surveillance for invasive pneumococcal disease during 2000-2005 in a population of children who received 7-valent pneumococcal conjugate vaccine.

Penicillin-resistant pneumococcal meningitis: high antibiotic exposure impedes new vaccine protection.

P304

244-256

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1056/NEJMOA0800836

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

360

http://www.w3.org/2001/XMLSchema#string

P50

Kathleen A. Shutt

William Schaffner

P577

2009-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19144940

http://www.w3.org/2001/XMLSchema#string

P921

P932

4663990

http://www.w3.org/2001/XMLSchema#string